This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slipped 7.0% to $8.24 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.7% to 26,081.72 and Dow Jones Industrial Average falling 0.6% to 52,064.10.
This was the stock's fifth consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 59.9% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 4.0% to $5.04, Fortress Biotech Inc. fell 2.3% to $2.57, and Viking Therapeutics Inc. fell 1.74% to $32.13.
Trading volume totaled 646,561, compared to the 50-day average of 434,821.
Data source: Dow Jones Market Data, FactSet